Enveric Biosciences Reports Positive Preclinical Results from Phototoxicity Analysis for Lead Neuroplastogen Candidate EB-003
Go back to Enveric Biosciences Reports Positive Preclinical Results from Phototoxicity Analysis for Lead Neuroplastogen Candidate EB-003| (NASDAQ: ENVB) | Delayed: 1.32 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.32 | 52 Week High | $ | |||
| Open | $1.32 | 52 Week Low | $ | |||
| Day High | $1.32 | P/E | N/A | |||
| Day Low | $1.32 | EPS | $ | |||
| Volume | 37 | |||||
